Terns Pharmaceuticals Inc’s recent filing unveils that its Chief Business Officer Jung Melita Sun acquired Company’s shares for reported $11498.0 on Nov 30 ’24. In the deal valued at $5.11 per share,2,250 shares were bought. As a result of this transaction, Jung Melita Sun now holds 2,250 shares worth roughly $7470.0.
Then, Burroughs Amy L. bought 510 shares, generating $2,606 in total proceeds. Upon buying the shares at $5.11, the Chief Executive Officer now owns 19,609 shares.
Before that, Kuriakose Emil sold 4,481 shares. Terns Pharmaceuticals Inc shares valued at $25,607 were divested by the Chief Medical Officer at a price of $5.71 per share. As a result of the transaction, Kuriakose Emil now holds 54,269 shares, worth roughly $0.18 million.
William Blair initiated its Terns Pharmaceuticals Inc [TERN] rating to a Mkt perform in a research note published recently. A number of analysts have revised their coverage, including Oppenheimer’s analysts, who began to cover the stock in late October with a ‘”an Outperform”‘ rating. Mizuho began covering TERN with “Buy” recommendation on June 22, 2023. Jefferies started covering the stock on June 07, 2023. It rated TERN as “a Buy”.
Price Performance Review of TERN
On Tuesday, Terns Pharmaceuticals Inc [NASDAQ:TERN] saw its stock fall -5.41% to $3.32. Over the last five days, the stock has gained 5.06%. Terns Pharmaceuticals Inc shares have fallen nearly -40.07% since the year began. Nevertheless, the stocks have fallen -49.31% over the past one year. While a 52-week high of $11.40 was reached on 01/06/25, a 52-week low of $3.08 was recorded on 03/17/25. SMA at 50 days reached $4.00, while 200 days put it at $6.55.
Levels Of Support And Resistance For TERN Stock
The 24-hour chart illustrates a support level at 3.21, which if violated will result in even more drops to 3.11. On the upside, there is a resistance level at 3.48. A further resistance level may holdings at 3.64. The Relative Strength Index (RSI) on the 14-day chart is 40.93, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.03, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 62.50%. Stochastics %K at 48.96% indicates the stock is a holding.
How much short interest is there in Terns Pharmaceuticals Inc?
A steep rise in short interest was recorded in Terns Pharmaceuticals Inc stocks on 2025-03-14, growing by 31889.0 shares to a total of 5.95 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 5.92 million shares. There was a rise of 0.54%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on May 31, 2023 when ROTH MKM began covering the stock and recommended ‘”a Buy”‘ rating along with a $23 price target.
